Donald Kellerman, SVP,Clinical Dev & Med Affairs at Map Pharmaceuticals, holds 0.00 shares in Map Pharmaceuticals (Ticker: ~MAPP), holds 56.33K shares in Zosano Pharma (Ticker: ZSANQ), holds 0.00 shares in Tonix Pharma (Ticker: TNXP). Most recently, Donald Kellerman ― shares of Map Pharmaceuticals on ― for an estimated value of ―.

See the Hottest Stocks Based on Insider Trading >

Donald Kellerman
Map Pharmaceuticals (~MAPP)
SVP,Clinical Dev & Med Affairs

Ranked #34,827 out of 98,564 Corporate Insiders

Profitable Transactions

1 out of 2 Profitable Transactions

Average Return

+33.80%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

Donald Kellerman does not currently own shares as a corporate insider.

A breakdown of Donald Kellerman's holdings

See the Top Stocks by Insiders

Insider Roles

Tonix Pharma
(TNXP)

Senior Vice President, Clinical Development and Me

Roles that Donald Kellerman holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Zosano Pharma
(ZSANQ)

Rating:Informative Sell

Date:Jun 07, 2021 - Jun 07, 2022

Return:+98.20%

The most profitable trade made by Donald Kellerman

See the Latest Stocks Traded by Insiders

Donald Kellerman's Trading History

~MAPP

Map Pharmaceuticals

―

ZSANQ

Zosano Pharma

Apr 01, 2022

―

Informative Sell

841.26

$1.13K

TNXP

Tonix Pharma

―

Senior Vice President, Clinical Development and Me

―

$0.00

List of latest transactions for each holding click on a transaction to see Donald Kellerman's performance on stock

See All Insider Trading from Today

Donald Kellerman insider profile FAQ

What is the percentage of profitable transactions made by Donald Kellerman?

The percentage of profitable transactions made by Donald Kellerman is 50%.

What is the average return per transaction made by Donald Kellerman?

The average return per transaction made by Donald Kellerman is 33.80%.

What stocks does Donald Kellerman hold?

Donald Kellerman holds: ~MAPP, ZSANQ, TNXP stocks.

What was Donald Kellerman’s latest transaction?

Donald Kellerman latest transaction was an Uninformative Buy of ―.

What was Donald Kellerman's most profitable transaction?

Donald Kellerman’s most profitable transaction was an Informative Sell of ZSANQ stock on June 7, 2021. The return on the trade was 98.20%.

What is Donald Kellerman's role in Map Pharmaceuticals?

Donald Kellerman's role in Map Pharmaceuticals is SVP,Clinical Dev & Med Affairs.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Donald Kellerman Insider Profile

Donald Kellerman Map Pharmaceuticals (~MAPP)SVP,Clinical Dev & Med Affairs